The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management […]
Recent Content
- 1st 4 patients in AML treatment combo trial show response
- A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma
- The efficacy and safety of CAR-T therapy in relapsed or refractory multiple myeloma patients: a systematic review and meta-analysis
- (no title)
- (no title)
- (no title)
- (no title)
- (no title)
- FDA grants orphan drug status to ARB1002 for pancreatic cancer
- Is Less “Sufficient” and “Safe” in the MRD Era – Outcomes of Autologous Stem-Cell Transplant as per Melphalan Dose in Patients with Multiple Myeloma